---
title: "Accendra Health, Inc. (ACH.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ACH.US.md"
symbol: "ACH.US"
name: "Accendra Health, Inc."
industry: "Health Care Distributors"
datetime: "2026-05-19T19:14:18.993Z"
locales:
  - [en](https://longbridge.com/en/quote/ACH.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ACH.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ACH.US.md)
---

# Accendra Health, Inc. (ACH.US)

## Company Overview

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies.

| Item | Detail |
|------|--------|
| Industry | Health Care Distributors |
| Exchange | US Market |
| Website | [www.accendrahealth.com](https://www.accendrahealth.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:12.000Z

**Overall: D (0.69)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 15 / 16 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -0.01% |  |
| Net Profit YoY | -195.84% |  |
| P/B Ratio | -0.45 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 209839343.48 |  |
| Revenue | 2715928000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -198.35% | E |
| Profit Margin | -39.84% | E |
| Gross Margin | 44.29% | B |
| Revenue YoY | -0.01% | D |
| Net Profit YoY | -195.84% | E |
| Total Assets YoY | -50.25% | E |
| Net Assets YoY | -181.40% | E |
| Cash Flow Margin | 10.79% | D |
| OCF YoY | -0.01% | D |
| Turnover | 0.75 | B |
| Gearing Ratio | 119.24% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Accendra Health, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-0.01%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-195.84%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-0.45",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "209839343.48",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2715928000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-198.35%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-39.84%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "44.29%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-0.01%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-195.84%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-50.25%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-181.40%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "10.79%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-0.01%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.75",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "119.24%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.19 | 7/16 | - | - | - |
| PB | -0.45 | 10/16 | - | - | - |
| PS (TTM) | 0.08 | 1/16 | 0.09 | 0.07 | 0.02 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Henry Schein (HSIC.US) | B | C | A | D | B | B |
| 02 | ZeroStack (ZSTK.US) | E | B | A | A | B | B |
| 03 | McKesson (MCK.US) | E | B | A | E | B | C |
| 04 | Cencora (COR.US) | B | B | A | E | C | C |
| 05 | Cardinal Health (CAH.US) | E | C | A | E | B | C |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-12T04:00:00.000Z

Total Analysts: **6**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 2 | 33% |
| Hold | 2 | 33% |
| Underweight | 2 | 33% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.85 |
| Highest Target | 5.00 |
| Lowest Target | 2.25 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ACH.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ACH.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ACH.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ACH.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**